ArticleNature communications2018

A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity.

Marta Compte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.